Your Article Summary
See Latest ArticlesFuture drugs for migraine
Internal and Emergency Medicine, 06/26/09
Farinelli I et al. - The pipeline of future compounds for the treatment of acute migraine headaches include TPRV1 antagonists, prostaglandin E receptor 4 (EP4) receptor antagonists, serotonin 5HT1F receptor agonists and nitric oxide synthase inhibitors. The immediate future of a preventative treatment for migraine headaches is well represented by botulinum toxin type-A, glutamate NMDA receptor antagonists, gap-junction blocker tonabersat and an angiotensin type 1 blocker candesartan.
Related Articles
Topiramate in migraine progression
The Journal of Headache and Pain, 10/21/09
Relevance Score: 96%
CSD, BBB and MMP-9 elevations: animal experiments versus clinical phenomena in migraine
Expert Review of Neurotherapeutics, 11/12/09
Relevance Score: 94%
Aura migraines : Aura migraines double stroke risk
Internet Source, 11/02/09
Relevance Score: 94%
Migraine Chronification - Concept and Risk Factors
Discovery Medicine, 10/27/09
Relevance Score: 94%
Normal Cortical Energy Metabolism in Migrainous Stroke. A 31P-MR Spectroscopy Study
Stroke, 10/20/09
Relevance Score: 94%
Today in Headache...keeping you current
Receive free subspecialty "5-minute updates" via email
Visual noise selectively degrades vision in migraine
Investigative Ophthalmology and Visual Science, 12/18/09
Developmental changes of the contingent negative variation in migraine and healthy children
The Journal of Headache and Pain, 12/18/09
Auditory Brainstem Evoked Responses In Migraine Patients
The Internet Journal of Neurology, 12/18/09